1. Home
  2. PDSB vs HTCR Comparison

PDSB vs HTCR Comparison

Compare PDSB & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • HTCR
  • Stock Information
  • Founded
  • PDSB 2005
  • HTCR 2009
  • Country
  • PDSB United States
  • HTCR Japan
  • Employees
  • PDSB N/A
  • HTCR N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • HTCR EDP Services
  • Sector
  • PDSB Health Care
  • HTCR Technology
  • Exchange
  • PDSB Nasdaq
  • HTCR Nasdaq
  • Market Cap
  • PDSB 58.7M
  • HTCR 48.1M
  • IPO Year
  • PDSB N/A
  • HTCR 2022
  • Fundamental
  • Price
  • PDSB $0.96
  • HTCR $0.62
  • Analyst Decision
  • PDSB Strong Buy
  • HTCR
  • Analyst Count
  • PDSB 3
  • HTCR 0
  • Target Price
  • PDSB $10.00
  • HTCR N/A
  • AVG Volume (30 Days)
  • PDSB 795.8K
  • HTCR 79.1K
  • Earning Date
  • PDSB 05-14-2025
  • HTCR 05-13-2025
  • Dividend Yield
  • PDSB N/A
  • HTCR 5.48%
  • EPS Growth
  • PDSB N/A
  • HTCR N/A
  • EPS
  • PDSB N/A
  • HTCR 0.23
  • Revenue
  • PDSB N/A
  • HTCR $30,290,930.00
  • Revenue This Year
  • PDSB N/A
  • HTCR $47.99
  • Revenue Next Year
  • PDSB N/A
  • HTCR N/A
  • P/E Ratio
  • PDSB N/A
  • HTCR $3.14
  • Revenue Growth
  • PDSB N/A
  • HTCR 47.63
  • 52 Week Low
  • PDSB $1.05
  • HTCR $0.55
  • 52 Week High
  • PDSB $4.42
  • HTCR $3.38
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 32.49
  • HTCR 32.37
  • Support Level
  • PDSB $1.19
  • HTCR $0.66
  • Resistance Level
  • PDSB $1.41
  • HTCR $0.85
  • Average True Range (ATR)
  • PDSB 0.10
  • HTCR 0.10
  • MACD
  • PDSB -0.03
  • HTCR -0.01
  • Stochastic Oscillator
  • PDSB 2.11
  • HTCR 30.00

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company. It provides software through two business units. The first business unit includes a customer experience management business that has been in existence for 12 years. The customer experience management platform includes marketing, sales, service and content management systems, as well as other tools and integrations, that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, its DX division, is a digital transformation business that provides customers with robotics process automation, process mining and task mining to accelerate the digital transformation of enterprises.

Share on Social Networks: